CERE-120 for Parkinson’s Disease – Video

CERE-120 is an experimental drug currently in clinical trials. It employs a vector to transfer the gene that makes neurturin directly into brain cells most affected by Parkinson's disease. Neurturin is a neurotrophic factor shown in laboratory experiments to restore damaged dopamine cells and protect them from further degeneration.

See the original post here:
CERE-120 for Parkinson's Disease - Video

Parkinson’s Disease: Diagnosis, Causes and Treatment.

Juan Sanchez-Ramos, MD, PhD, Medical Director, Parkinson Research Foundation Dr. Juan Sanchez-Ramos is Professor of Neurology at the University of South Florida in Tampa where he holds the Helen Ellis Endowed Chair for Parkinson's disease Research and is the Chair for this 5th Annual PRF Parkinson's Disease Conference.

View post:
Parkinson's Disease: Diagnosis, Causes and Treatment.

Parkinson’s Disease: Spotlight on Stem Cell Research – Arnold Kriegstein

(Part 2 of 3) Arnold Kriegstein, MD, Ph.D., spoke at the "Spotlight on Parkinson's Disease," an educational event presented at the CIRM Governing Board meeting on May 7, 2008. Kriegstein reviewed the limitations of previous Parkinson's clinical trials and discussed the prospects for stem cell-based cell replacement therapies for Parkinson's disease.

Read this article:
Parkinson's Disease: Spotlight on Stem Cell Research - Arnold Kriegstein

Stem Cells and Parkinson’s Disease

(Part 5 of 7) Evan Henry, a Parkinson's disease patient advocate, and Birgitt Schuele, a professor at The Parkinson's Institute, spoke at "Synapses Firing: Connections Made", a patient advocacy event hosted by the California stem cell funding agency (CIRM). The 100+ people in attendance heard from patient advocates about living with neurodegenerative disease and from scientists about recent progress in stem cell research that may lead to new treatments. The event was held on May 7th 2011, at UC-Irvine's Sue and Bill Gross Stem Cell Research Center.

Link:
Stem Cells and Parkinson's Disease